Heron Therapeutics, Inc. Common Stock (NASDAQ: HRTX) last traded at $0.318, up 2.91% on the session. The quote above updates while this page is open; the figures below are drawn from Heron Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Heron Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker HRTX. Its market capitalisation is $60.37 million.
Valuation measures for Heron Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $60.37M |
|---|---|
| Enterprise value | $285.01M |
| Price / sales | 0.40 |
| Price / book | 8.74 |
| Beta | 1.74 |
Trailing-twelve-month figures tagged in Heron Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $151.18M |
|---|---|
| Net income (TTM) | -$34.05M |
| EPS (TTM) | -$0.180 |
| Gross margin | 70.07% |
| Operating margin | -7.19% |
| Return on equity | -492.89% |
| Cash | $20.72M |
Range and volume for HRTX over the past 52 weeks.
| 52-week high | $1.58 |
|---|---|
| 52-week low | $0.300 |
| Volume | 3.01M |
| Average volume | 3.52M |
| Previous close | $0.309 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.